First Trust Nasdaq Pharmaceuticals ETF (FTXH)

Assets	$20.43M
Expense Ratio	0.60%
PE Ratio	16.08
Shares Out	750,002
Dividend (ttm)	$0.39
Dividend Yield	1.45%
Ex-Dividend Date	Jun 27, 2024
Payout Ratio	23.58%
1-Year Return	+3.43%

Volume	809
Open	27.02
Previous Close	27.27
Day's Range	26.97 - 27.03
52-Week Low	23.85
52-Week High	28.41
Beta	0.60
Holdings	52
Inception Date	Sep 20, 2016

About FTXH

Fund Home Page

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is issued by First Trust.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NASDAQ
• Ticker Symbol: FTXH
• ETF Provider: First Trust
• Index Tracked: Nasdaq US Smart Pharmaceuticals Index

Top 10 Holdings

55.23% of assets

Name	Symbol	Weight
Pfizer Inc.	PFE	7.54%
Merck & Co., Inc.	MRK	7.36%
AbbVie Inc.	ABBV	6.92%
Johnson & Johnson	JNJ	6.51%
Bristol-Myers Squibb Company	BMY	5.89%
United Therapeutics Corporation	UTHR	4.59%
Eli Lilly and Company	LLY	4.35%
Amgen Inc.	AMGN	4.13%
Vertex Pharmaceuticals Incorporated	VRTX	4.04%
Regeneron Pharmaceuticals, Inc.	REGN	3.92%

Dividends

Ex-Dividend	Amount	Pay Date
Jun 27, 2024	$0.1284	Jun 28, 2024
Mar 21, 2024	$0.0676	Mar 28, 2024
Dec 22, 2023	$0.1232	Dec 29, 2023
Sep 22, 2023	$0.0725	Sep 29, 2023
Jun 27, 2023	$0.1179	Jun 30, 2023
Mar 24, 2023	$0.1001	Mar 31, 2023